mRNA-2808

· ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA-2808, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]